Organ-Preserving Approach in Bladder Cancer: Assessment of the Current Situation

Intravesical bacillus Calmette-Guerin (BCG) therapy is the gold standard treatment option in high-risk non-invasive bladder cancer. However, BCG is a very toxic agent. A significant proportion of patients have BCG intolerance after beginning intravesical treatment. Radical cystectomy is the recommen...

Full description

Saved in:
Bibliographic Details
Published in:Üroonkoloji bülteni 2018-06, Vol.17 (2), p.63-67
Main Authors: Girgin, Reha, Mungan, N. Aydın
Format: Article
Language:English
Subjects:
Acids
Bladder cancer
Cancer therapies
Cell cycle
Cell division
Chemotherapy
Endoscopy
Immunotherapy
Metastasis
Permeability
Photodynamic therapy
Response rates
Tıp
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c248t-9b436e7a1738a9fb54a1ab60ed23580e2f70a4e1d44bed27c5c34b662d573d933
cites
container_end_page 67
container_issue 2
container_start_page 63
container_title Üroonkoloji bülteni
container_volume 17
creator Girgin, Reha
Mungan, N. Aydın
description Intravesical bacillus Calmette-Guerin (BCG) therapy is the gold standard treatment option in high-risk non-invasive bladder cancer. However, BCG is a very toxic agent. A significant proportion of patients have BCG intolerance after beginning intravesical treatment. Radical cystectomy is the recommended approach for patients with either BCG failure or BCG intolerance. Alternative intravesical salvage treatments are needed for patients who cannot tolerate radical cystectomy due to comorbidities or who refuse surgery. In this review, current intravesical treatment alternatives to radical cystectomy in intravesical BCG failure are discussed with oncologic outcomes.
doi_str_mv 10.4274/uob.967
format article
fullrecord <record><control><sourceid>proquest_ideal</sourceid><recordid>TN_cdi_proquest_journals_2117202266</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2117202266</sourcerecordid><originalsourceid>FETCH-LOGICAL-c248t-9b436e7a1738a9fb54a1ab60ed23580e2f70a4e1d44bed27c5c34b662d573d933</originalsourceid><addsrcrecordid>eNpNkE1Lw0AQhhdRsNTiX1jw4Cl1v7KbeIuxaiHQgnpeNsmk3ZJu6m4i-O9NqVBPM_PyMDM8CN1SMhdMiYehK-epVBdowqhQEWOKXP7rr9EshB0hhKqEsERO0HrlN8ZFaw8B_Ld1G5wdDr4z1RZbh59aU9fgcW5cBf4RZyFACHtwPe4a3G8B54P3x_Hd9oPpbedu0FVj2gCzvzpFny-Lj_wtKlavyzwrooqJpI_SUnAJylDFE5M2ZSwMNaUkUDMeJwRYo4gRQGshyjFTVVxxUUrJ6ljxOuV8iu5Oe8dvvwYIvd51g3fjSc0oVYwwJuVI3Z8oW4NpO9daB2dw-bzICq0EUcmZrHwXgodGH7zdG_-jKdFHt3p0q0e3_Bcy8Wq-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2117202266</pqid></control><display><type>article</type><title>Organ-Preserving Approach in Bladder Cancer: Assessment of the Current Situation</title><source>Publicly Available Content Database</source><creator>Girgin, Reha ; Mungan, N. Aydın</creator><contributor>Koşan,Murat Tevfik</contributor><creatorcontrib>Girgin, Reha ; Mungan, N. Aydın ; Koşan,Murat Tevfik</creatorcontrib><description>Intravesical bacillus Calmette-Guerin (BCG) therapy is the gold standard treatment option in high-risk non-invasive bladder cancer. However, BCG is a very toxic agent. A significant proportion of patients have BCG intolerance after beginning intravesical treatment. Radical cystectomy is the recommended approach for patients with either BCG failure or BCG intolerance. Alternative intravesical salvage treatments are needed for patients who cannot tolerate radical cystectomy due to comorbidities or who refuse surgery. In this review, current intravesical treatment alternatives to radical cystectomy in intravesical BCG failure are discussed with oncologic outcomes.</description><identifier>ISSN: 2147-2270</identifier><identifier>ISSN: 2147-2122</identifier><identifier>EISSN: 2147-2270</identifier><identifier>DOI: 10.4274/uob.967</identifier><language>eng</language><publisher>Istanbul: Üroonkoloji Derneği</publisher><subject>Acids ; Bladder cancer ; Cancer therapies ; Cell cycle ; Cell division ; Chemotherapy ; Endoscopy ; Immunotherapy ; Metastasis ; Permeability ; Photodynamic therapy ; Response rates ; Tıp</subject><ispartof>Üroonkoloji bülteni, 2018-06, Vol.17 (2), p.63-67</ispartof><rights>2018. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c248t-9b436e7a1738a9fb54a1ab60ed23580e2f70a4e1d44bed27c5c34b662d573d933</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2117202266/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2117202266?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,27924,27925,37012,44590,75126</link.rule.ids></links><search><contributor>Koşan,Murat Tevfik</contributor><creatorcontrib>Girgin, Reha</creatorcontrib><creatorcontrib>Mungan, N. Aydın</creatorcontrib><title>Organ-Preserving Approach in Bladder Cancer: Assessment of the Current Situation</title><title>Üroonkoloji bülteni</title><description>Intravesical bacillus Calmette-Guerin (BCG) therapy is the gold standard treatment option in high-risk non-invasive bladder cancer. However, BCG is a very toxic agent. A significant proportion of patients have BCG intolerance after beginning intravesical treatment. Radical cystectomy is the recommended approach for patients with either BCG failure or BCG intolerance. Alternative intravesical salvage treatments are needed for patients who cannot tolerate radical cystectomy due to comorbidities or who refuse surgery. In this review, current intravesical treatment alternatives to radical cystectomy in intravesical BCG failure are discussed with oncologic outcomes.</description><subject>Acids</subject><subject>Bladder cancer</subject><subject>Cancer therapies</subject><subject>Cell cycle</subject><subject>Cell division</subject><subject>Chemotherapy</subject><subject>Endoscopy</subject><subject>Immunotherapy</subject><subject>Metastasis</subject><subject>Permeability</subject><subject>Photodynamic therapy</subject><subject>Response rates</subject><subject>Tıp</subject><issn>2147-2270</issn><issn>2147-2122</issn><issn>2147-2270</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpNkE1Lw0AQhhdRsNTiX1jw4Cl1v7KbeIuxaiHQgnpeNsmk3ZJu6m4i-O9NqVBPM_PyMDM8CN1SMhdMiYehK-epVBdowqhQEWOKXP7rr9EshB0hhKqEsERO0HrlN8ZFaw8B_Ld1G5wdDr4z1RZbh59aU9fgcW5cBf4RZyFACHtwPe4a3G8B54P3x_Hd9oPpbedu0FVj2gCzvzpFny-Lj_wtKlavyzwrooqJpI_SUnAJylDFE5M2ZSwMNaUkUDMeJwRYo4gRQGshyjFTVVxxUUrJ6ljxOuV8iu5Oe8dvvwYIvd51g3fjSc0oVYwwJuVI3Z8oW4NpO9daB2dw-bzICq0EUcmZrHwXgodGH7zdG_-jKdFHt3p0q0e3_Bcy8Wq-</recordid><startdate>20180601</startdate><enddate>20180601</enddate><creator>Girgin, Reha</creator><creator>Mungan, N. Aydın</creator><general>Üroonkoloji Derneği</general><general>Galenos Publishing House</general><scope>AAYXX</scope><scope>CITATION</scope><scope>IEBAR</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20180601</creationdate><title>Organ-Preserving Approach in Bladder Cancer: Assessment of the Current Situation</title><author>Girgin, Reha ; Mungan, N. Aydın</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c248t-9b436e7a1738a9fb54a1ab60ed23580e2f70a4e1d44bed27c5c34b662d573d933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acids</topic><topic>Bladder cancer</topic><topic>Cancer therapies</topic><topic>Cell cycle</topic><topic>Cell division</topic><topic>Chemotherapy</topic><topic>Endoscopy</topic><topic>Immunotherapy</topic><topic>Metastasis</topic><topic>Permeability</topic><topic>Photodynamic therapy</topic><topic>Response rates</topic><topic>Tıp</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Girgin, Reha</creatorcontrib><creatorcontrib>Mungan, N. Aydın</creatorcontrib><collection>CrossRef</collection><collection>Idealonline online kütüphane - Journals</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Üroonkoloji bülteni</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Girgin, Reha</au><au>Mungan, N. Aydın</au><au>Koşan,Murat Tevfik</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Organ-Preserving Approach in Bladder Cancer: Assessment of the Current Situation</atitle><jtitle>Üroonkoloji bülteni</jtitle><date>2018-06-01</date><risdate>2018</risdate><volume>17</volume><issue>2</issue><spage>63</spage><epage>67</epage><pages>63-67</pages><issn>2147-2270</issn><issn>2147-2122</issn><eissn>2147-2270</eissn><abstract>Intravesical bacillus Calmette-Guerin (BCG) therapy is the gold standard treatment option in high-risk non-invasive bladder cancer. However, BCG is a very toxic agent. A significant proportion of patients have BCG intolerance after beginning intravesical treatment. Radical cystectomy is the recommended approach for patients with either BCG failure or BCG intolerance. Alternative intravesical salvage treatments are needed for patients who cannot tolerate radical cystectomy due to comorbidities or who refuse surgery. In this review, current intravesical treatment alternatives to radical cystectomy in intravesical BCG failure are discussed with oncologic outcomes.</abstract><cop>Istanbul</cop><pub>Üroonkoloji Derneği</pub><doi>10.4274/uob.967</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2147-2270
ispartof Üroonkoloji bülteni, 2018-06, Vol.17 (2), p.63-67
issn 2147-2270
2147-2122
2147-2270
language eng
recordid cdi_proquest_journals_2117202266
source Publicly Available Content Database
subjects Acids
Bladder cancer
Cancer therapies
Cell cycle
Cell division
Chemotherapy
Endoscopy
Immunotherapy
Metastasis
Permeability
Photodynamic therapy
Response rates
Tıp
title Organ-Preserving Approach in Bladder Cancer: Assessment of the Current Situation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T20%3A17%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_ideal&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Organ-Preserving%20Approach%20in%20Bladder%20Cancer:%20Assessment%20of%20the%20Current%20Situation&rft.jtitle=%C3%9Croonkoloji%20b%C3%BClteni&rft.au=Girgin,%20Reha&rft.date=2018-06-01&rft.volume=17&rft.issue=2&rft.spage=63&rft.epage=67&rft.pages=63-67&rft.issn=2147-2270&rft.eissn=2147-2270&rft_id=info:doi/10.4274/uob.967&rft_dat=%3Cproquest_ideal%3E2117202266%3C/proquest_ideal%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c248t-9b436e7a1738a9fb54a1ab60ed23580e2f70a4e1d44bed27c5c34b662d573d933%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2117202266&rft_id=info:pmid/&rfr_iscdi=true